The pharmacological classification of adrenergic alpha 1 and alpha 2 receptors and their mechanisms of action.
D000109:Acetylcholine / Q000378:metabolism; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001013:Aorta, Thoracic / Q000294:innervation / Q000378:metabolism; D002799:Cholinergic Fibers / Q000502:physiology; D003714:Denervation; D004558:Electric Stimulation; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000294:innervation; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000294:innervation / Q000378:metabolism*; D009131:Muscle, Smooth, Vascular / Q000294:innervation / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D011817:Rabbits; D011941:Receptors, Adrenergic / Q000378:metabolism*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D000109:Acetylcholine; D009638:Norepinephrine; D004837:Epinephrine